Cooperative Regulation of the Cell Division Cycle by the Protein Kinases RAF and AKT

REFERENCES

• Albanese, C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., and Pestell R. G.. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589–23597.
   PubMed Web of Science ®Google Scholar
• Amanatullah, D. F., Zafonte B. T., Albanese C., Fu M., Messiers C., Hassell J., and Pestell R. G.. 2001. Ras regulation of cyclin D1 promoter. Methods Enzymol. 333:116–127.
   PubMedGoogle Scholar
• Aziz, N., Cherwinski H., and McMahon M.. 1999. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol. Cell. Biol. 19:1101–1115.
   PubMedGoogle Scholar
• Boehm, M., Yoshimoto T., Crook M. F., Nallamshetty S., True A., Nabel G. J., and Nabel E. G.. 2002. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21:3390–3401.
   PubMed Web of Science ®Google Scholar
• Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689.
   PubMed Web of Science ®Google Scholar
• Chin, L., Pomerantz J., Polsky D., Jacobson M., Cohen C., Cordon-Cardo C., Horner II J. W., and DePinho R. A.. 1997. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11:2822–2834.
   PubMed Web of Science ®Google Scholar
• Chin, L., Tam A., Pomerantz J., Wong M., Holash J., Bardeesy N., Shen Q., O'Hagan R., Pantginis J., Zhou H., Horner II J. W., Cordon-Cardo C., Yancopoulos G. D., and DePinho R. A.. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400:468–472.
   PubMed Web of Science ®Google Scholar
• Coats, S., Flanagan M. W., Nourse J., and Roberts J. M.. 1996. Requirement of p27 Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877–880.
   PubMed Web of Science ®Google Scholar
• Coleman, M. L., Marshall C. J., and Olson M. F.. 2003. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 22:2036–2046.
   PubMed Web of Science ®Google Scholar
• Connor, M. K., Kotchetkov R., Cariou S., Resch A., Lupetti R., Beniston R. G., Melchior F., Hengst L., and Slingerland J. M.. 2003. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Mol. Biol. Cell 14:201–213.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., Aziz N., and McMahon M.. 1999. The repertoire of Fos and Jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:330–341.
   PubMed Web of Science ®Google Scholar
• Davies, H., Bignell G. R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M. J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B. A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G. J., Bigner D. D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J. W., Leung S. Y., Yuen S. T., Weber B. L., Seigler H. F., Darrow T. L., Paterson H., Marais R., Marshall C. J., Wooster R., Stratton M. R., and Futreal P. A.. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949–954.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., Cheng M., Roussel M. F., and Sherr C. J.. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511.
   PubMed Web of Science ®Google Scholar
• Dolbeare, F., Gratzner H., Pallavicini M. G., and Gray J. W.. 1983. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80:5573–5577.
   PubMed Web of Science ®Google Scholar
• Edamatsu, H., Kaziro Y., and Itoh H.. 2002. Differential display of mRNAs regulated by G-protein signaling. Methods Enzymol. 345:521–529.
   PubMedGoogle Scholar
• Edamatsu, H., Kaziro Y., and Itoh H.. 2000. LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 5:849–858.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., Randel E., Gurley K. E., Roberts J. M., and Kemp C. J.. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177–180.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., Rivkin M., Tasch M., Porter P., Carow C. E., Firpo E., Polyak K., Tsai L. H., Broudy V., Perlmutter R. M., Kaushansky K., and Roberts J. M.. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733–744.
   PubMed Web of Science ®Google Scholar
• Gille, H., and Downward J.. 1999. Multiple Ras effector pathways contribute to G1 cell cycle progression. J. Biol. Chem. 274:22033–22040.
   PubMed Web of Science ®Google Scholar
• Guerra, C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M.. 2003. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4:111–120.
   PubMed Web of Science ®Google Scholar
• Hara, T., Kamura T., Nakayama K., Oshikawa K., Hatakeyama S., and Nakayama K.-I.. 2001. Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 276:48937–48943.
   PubMed Web of Science ®Google Scholar
• Hruban, R. H., Iacobuzio-Donahue C., Wilentz R. E., Goggins M., and Kern S. E.. 2001. Molecular pathology of pancreatic cancer. Cancer J. 7:251–258.
   PubMed Web of Science ®Google Scholar
• Ishida, N., Hara T., Kamura T., Yoshida M., Nakayama K., and Nakayama K. I.. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355–14358.
   PubMed Web of Science ®Google Scholar
• Jones, S. M., and Kazlauskas A.. 2001. Growth factor-dependent signaling and cell cycle progression. FEBS Lett. 490:110–116.
   PubMed Web of Science ®Google Scholar
• Jones, S. M., and Kazlauskas A.. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165–172.
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., Kineman R. D., Manova-Todorova K. O., Soares V. C., Hoffman E. S., Ono M., Khanam D., Hayday A. C., Frohman L. A., and Koff A.. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721–732.
   PubMed Web of Science ®Google Scholar
• Kohn, A. D., Barthel A., Kovacina K. S., Boge A., Wallach B., Summers S. A., Birnbaum M. J., Scott P. H., Lawrence J. C., Jr., and Roth R. A.. 1998. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J. Biol. Chem. 273:11937–11943.
   PubMedGoogle Scholar
• Liang, J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M. K., Han K., Lee J. H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., and Slingerland J. M.. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:1153–1160.
   PubMed Web of Science ®Google Scholar
• Lloyd, A. C. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev. 8:43–48.
   PubMedGoogle Scholar
• Lloyd, A. C., Obermuller F., Staddon S., Barth C. F., McMahon M., and Land H.. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11:663–677.
   PubMedGoogle Scholar
• Malek, N. P., Sundberg H., McGrew S., Nakayama K., Kyriakidis T. R., and Roberts J. M.. 2001. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27 Kip1 in G1 and S phase. Nature 413:323–327.
   PubMedGoogle Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• McCarthy, S. A., Aziz N., and McMahon M.. 1997. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, ΔRaf-1:ER. Methods Mol. Biol. 85:137–151.
   PubMedGoogle Scholar
• McCarthy, S. A., Samuels M. L., Pritchard C. A., Abraham J. A., and McMahon M.. 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9:1953–1964.
   PubMed Web of Science ®Google Scholar
• McCormick, F. 1999. Signalling networks that cause cancer. Trends Cell Biol. 9:M53–M56.
   PubMed Web of Science ®Google Scholar
• McCormick, F., and Wittinghofer A.. 1996. Interactions between Ras proteins and their effectors. Curr. Opin. Biotechnol. 7:449–456.
   PubMedGoogle Scholar
• McMahon, M., and Woods D.. 2001. Regulation of the p53 pathway by Ras, the plot thickens. Biochim. Biophys. Acta 1471:M63–M71.
   PubMedGoogle Scholar
• Medema, R. H., Kops G. J. P. L., Bos J. L., and Burgering B. M. T.. 2000. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787.
   PubMed Web of Science ®Google Scholar
• Mirza, A. M., Kohn A. D., Roth R. A., and McMahon M.. 2000. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ. 11:279–292.
   PubMedGoogle Scholar
• Muraoka, R. S., Lenferink A. E., Law B., Hamilton E., Brantley D. M., Roebuck L. R., and Arteaga C. L.. 2002. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Mol. Cell. Biol. 22:2204–2219.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., and Loh D. Y.. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., Nagahama H., Minamishima Y. A., Matsumoto M., Nakamichi I., Kitagawa K., Shirane M., Tsunematsu R., Tsukiyama T., Ishida N., Kitagawa M., Nakayama K., and Hatakeyama S.. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19:2069–2081.
   PubMed Web of Science ®Google Scholar
• Olson, M. F., Paterson H. F., and Marshall C. J.. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295–299.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., Nolan G. P., Scott M. L., and Baltimore D.. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Philipp-Staheli, J., Payne S. R., and Kemp C. J.. 2001. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res. 264:148–168.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana, P., Warne P. H., Khwaja A., Marte B. M., Pappin D., Das P., Waterfield M. D., Ridley A., and Downward J.. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
   PubMed Web of Science ®Google Scholar
• Samuels, M. L., Weber M. J., Bishop J. M., and McMahon M.. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13:6241–6252.
   PubMed Web of Science ®Google Scholar
• Sewing, A., Wiseman B., Lloyd A. C., and Land H.. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5588–5597.
   PubMed Web of Science ®Google Scholar
• Shayesteh, L., Lu Y., Kuo W. L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G. B., and Gray J. W.. 1999. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21:99–102.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 2000. Cell cycle control and cancer. Harvey Lect. 96:73–92.
   PubMedGoogle Scholar
• Sherr, C. J., and Roberts J. M.. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Shin, I., Yakes F. M., Rojo F., Shin N. Y., Bakin A. V., Baselga J., and Arteaga C. L.. 2002. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145–1152.
   PubMed Web of Science ®Google Scholar
• Slingerland, J., and Pagano M.. 2000. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183:10–17.
   PubMed Web of Science ®Google Scholar
• Sutterluty, H., Chatelain E., Marti A., Wirbelauer C., Senften M., Muller U., and Krek W.. 1999. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207–214.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and McCormick F.. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and McCormick F.. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3:233–245.
   PubMed Web of Science ®Google Scholar
• Thayer, S. P., di Magliano M. P., Heiser P. W., Nielsen C. M., Roberts D. J., Lauwers G. Y., Qi Y. P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A. L., and Hebrok M.. 2003. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851–856.
   PubMed Web of Science ®Google Scholar
• Treinies, I., Paterson H. F., Hooper S., Wilson R., and Marshall C. J.. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphotidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19:321–329.
   PubMedGoogle Scholar
• Tsao, H., Goel V., Wu H., Yang G., and Haluska F. G.. 2004. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Investig. Dermatol. 122:337–341.
   PubMed Web of Science ®Google Scholar
• Tsihlias, J., Kapusta L., and Slingerland J.. 1999. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50:401–423.
   PubMed Web of Science ®Google Scholar
• Tsvetkov, L. M., Yeh K. H., Lee S. J., Sun H., and Zhang H.. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664.
   PubMed Web of Science ®Google Scholar
• Wellbrock, C., Ogilvie L., Hedley D., Karasarides M., Martin J., Niculescu-Duvaz D., Springer C. J., and Marais R.. 2004. V599EB-RAF is an oncogene in melanocytes. Cancer Res. 64:2338–2342.
   PubMed Web of Science ®Google Scholar
• Westbrook, T. F., Nguyen D. X., Thrash B. R., and McCance D. J.. 2002. E7 abolishes Raf-induced arrest via mislocalization of p21Cip1. Mol. Cell. Biol. 22:7041–7052.
   PubMedGoogle Scholar
• Woods, D., Parry D., Cherwinski H., Bosch E., Lees E., and McMahon M.. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598–5611.
   PubMed Web of Science ®Google Scholar
• Zhou, B. P., Liao Y., Xia W., Spohn B., Lee M. H., and Hung M. C.. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245–252.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Woods D., McMahon M., and Bishop J. M.. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997–3007.
   PubMed Web of Science ®Google Scholar